Using MRI scans to predict tumor spread in bone and soft tissue cancers
Tests MRI image analysis in adults with bone or soft tissue cancer.
Plain-language title generated from the registry record
Registry title: Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor
Key facts
- Where
- Bologna, ItalySee the site
Where in Italy
- IRCCS Azienda Ospedaliero-Universitaria di BolognaBologna, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Trial code
- NCT06774729
- Record updated
- 14 January 2025
- Original description
The goal of this observational study is to evaluate the feasibility and clinical utility of radiomics to diagnose peri-lesion tumour infiltration of tumours in participants with a suspect of Bone Cancer Tumor or Soft Tissue Sarcoma (STS).Read full original descriptionShow less
Development of a Radiomics Model With 3T Multiparametric MR to Predict the Occurence of a Perilesional Infiltration of Muscoskeletal Tumor During the Pre- Surgery Planning
The goal of this observational study is to evaluate the feasibility and clinical utility of radiomics to diagnose peri-lesion tumour infiltration of tumours in participants with a suspect of Bone Cancer Tumor or Soft Tissue Sarcoma (STS).
The main questions it aims to answer are:
* is radiomics able to identify the ratio of participants truly diagnosed as positive to all those who had positive test results? * is radiomics able to identify the likelihood that a participant who has a negative test result indeed does not have the disease?
Participants eligible for this study will get a MRI as part of their regular medical care. The only difference is that their data will be recorded and anonymously analyzed.
Inclusion: Age over 18; suspect of soft tissue sarcoma with a indication for surgical treatment; suspect of bone cancer tumor with a indication for surgical treatment; To give informed consent.
Exclusion: simultaneous cancer or history of cancer in the last 5 years; acute or chronic serious conditions that could; contraindication to conduct a Contrast-enhanced magnetic resonance imaging (MRI) such as:; renal failure without dialysis; history of allergy to a paramagnetic contrast agent; claustrophobia; symptomatic epilepsy or history of epilepsy; cardiac pacemaker; infusion pump, prosthesis or any implant not compatible with MRI; pregnancy.